Tochigi, Japan

Yasuharu Itagaki



Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Ohazaishibashi, JP (1992)
  • Sapporo, JP (1997 - 2000)
  • Tochigi, JP (1996 - 2001)
  • Hokkaido, JP (2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Yasuharu Itagaki: Innovator in Biopharmaceuticals

Introduction

Yasuharu Itagaki is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of biopharmaceuticals, holding a total of 7 patents. His work focuses on developing innovative solutions that address critical health issues.

Latest Patents

Itagaki's latest patents include a human-derived glycoprotein that serves as a biologically active factor. This glycoprotein possesses anti-tumor activity, induces leukemia cell differentiation, enhances cellular immunology, stimulates vascular endothelial cell growth, and promotes hepatocyte growth. Additionally, he has developed a method for determining mastitis using keratin and casein amplified by primers. This novel primer is useful in reverse transcription polymerase chain reaction to amplify the α-casein gene and keratin gene found in milk. The method allows for a quick and accurate examination of mammalian mastitis without the need for excising mammary gland tissue.

Career Highlights

Yasuharu Itagaki is associated with Snow Brand Milk Products Co., Ltd., where he continues to innovate in the field of biopharmaceuticals. His research has led to advancements that have the potential to improve health outcomes for many individuals.

Collaborations

Itagaki has collaborated with notable coworkers such as Kanji Higashio and Morimasa Tanimoto. Their combined expertise has contributed to the success of various projects and patents.

Conclusion

Yasuharu Itagaki is a distinguished inventor whose work in biopharmaceuticals has made a significant impact. His innovative patents and collaborations highlight his commitment to advancing health science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…